A randomized comparison of the efficacy, side effects and patient convenience between vaginal and rectal administration of Cyclogest® when used for luteal phase support in ICSI treatment (Q56873436)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 June 2012

Language	Label	Description	Also known as
English	A randomized comparison of the efficacy, side effects and patient convenience between vaginal and rectal administration of Cyclogest® when used for luteal phase support in ICSI treatment	scientific article published on 20 June 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

A randomized comparison of the efficacy, side effects and patient convenience between vaginal and rectal administration of Cyclogest(®) when used for luteal phase support in ICSI treatment (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

based on heuristic

inferred from title

Haleh Rahmanpour Zanjani

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Malek-Mansour Aghsa

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Maryam Bagheri

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Fatemeh Davari-Tanha

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Reza Nasr

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

20 June 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Archives of Gynecology and Obstetrics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

286

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1049-1054

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

https://scigraph.springernature.com/pub.10.1007/s00404-012-2410-7

0 references

Luteal supplementation in in vitro fertilization: more questions than answers

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Use of antagonists in ovarian stimulation protocols

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

An update of luteal phase support in stimulated IVF cycles

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Reproductive biology and IVF: ovarian stimulation and luteal phase consequences

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Route of progesterone administration for luteal phase support may affect outcome of controlled ovarian hyperstimulation for IVF with ICSI using GnRH antagonist

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

A randomized comparison of side effects and patient convenience between Cyclogest suppositories and Endometrin tablets used for luteal phase support in IVF treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Luteal phase support in in vitro fertilization: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women(3).

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Comparison between different routes of progesterone administration as luteal phase support in infertility treatments

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Luteal support with vaginal micronized progesterone gel in assisted reproduction

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Progesterone for the luteal support of assisted reproductive technologies: clinical options

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

A randomised comparison of side effects and patient inconvenience of two vaginal progesterone formulations used for luteal support in in vitro fertilisation cycles

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2410-7

21 January 2018

Identifiers

10.1007/S00404-012-2410-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22714063%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56873436&oldid=2127456962"